Human amniotic membrane MSCs can act as a feeder layer to support the ex vivo expansion of cord blood hematopoietic stem cells for transplantation purposes
A bioengineered scaffold containing hypoxia‐preconditioned, allogeneic human mesenchymal stem cells (MSCs) combined with a beta‐adrenergic antagonist can treat wounds in diabetic mice
A new review article provides a balanced view of the potential of MSC therapy for COVID-19, with concerns regarding clinics offering unproven stem cell treatments in mind
Stem cell EV treatment promotes cell proliferation and alleviates senescence and may represent a new means to combat aging and treat degenerative disease